Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancer.
about
Multi-parametric analysis reveals enhanced G2-phase arrest of an optimized anti-HER2 antibody to inhibit breast cancer.Outcomes of re-treatment with first-line trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after (neo)adjuvant trastuzumab: A prospective multicenter study.Clinical applications of mouse models for breast cancer engaging HER2/neu.Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.ESE-1 Knockdown Attenuates Growth in Trastuzumab-resistant HER2+ Breast Cancer Cells.miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.SP1 promotes tumor angiogenesis and invasion by activating VEGF expression in an acquired trastuzumab‑resistant ovarian cancer model.Cytogenetic and immunohistochemical biomarker profiling of therapy-relevant factors in salivary gland carcinomas.STAT3 activation confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive breast cancerPosttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer
P2860
Q36385800-B7133B00-76C0-4456-8757-BE51ADBA352DQ37580443-CC7C6A6C-7092-4F92-A892-9ACFE1D9AA1BQ37607675-BB776474-9A00-4A00-8A68-92DE07519C77Q38935156-52CAF4ED-5F69-478D-A243-110621F3A8D4Q47350657-CE8D5997-2036-4F30-BC50-CC5141B2979FQ48549971-DF32FA46-C0D4-48FA-98F3-4D4D216017ADQ49358317-D51B4DA8-7269-4AF1-A8D8-6F3ABF2809B5Q50675747-CEAAD920-3DD5-4977-99AB-6D9301A1286BQ58778783-9A1DE875-E8EC-475C-A57B-9FC8A675CB2FQ58803127-98D616C2-F85A-4CEB-94AB-9399B45FB89B
P2860
Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Non-HER2 signaling pathways ac ...... HER2 therapy in breast cancer.
@en
type
label
Non-HER2 signaling pathways ac ...... HER2 therapy in breast cancer.
@en
prefLabel
Non-HER2 signaling pathways ac ...... HER2 therapy in breast cancer.
@en
P2860
P1476
Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancer
@en
P2093
Adela Madrid-Paredes
Miguel Ángel Calleja-Hernández
P2860
P2888
P304
P356
10.1007/S10549-015-3578-X
P407
P577
2015-09-23T00:00:00Z
P6179
1003156291